Kang CW - Search Results

1

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.

Betts BC, Locke FL, Sagatys EM, Pidala J, Walton K, Menges M, Reff J, Saha A, Djeu JY, Kiluk JV, Lee MC, Kim J, Kang CW, Tang CH, Frieling J, Lynch CC, List A, Rodriguez PC, Blazar BR, Conejo-Garcia JR, Del Valle JR, Hu CC, Anasetti C. Betts BC, et al. Among authors: kang cw. Front Immunol. 2018 Dec 6;9:2887. doi: 10.3389/fimmu.2018.02887. eCollection 2018. Front Immunol. 2018. PMID: 30574153 Free PMC article.

2

Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.

Tang CH, Chang S, Hashimoto A, Chen YJ, Kang CW, Mato AR, Del Valle JR, Gabrilovich DI, Hu CC. Tang CH, et al. Among authors: kang cw. Cancer Immunol Res. 2018 Jun;6(6):696-710. doi: 10.1158/2326-6066.CIR-17-0582. Epub 2018 Apr 12. Cancer Immunol Res. 2018. PMID: 29650518 Free PMC article.

3

Substituted imidazo[1,2-a]pyridines as β-strand peptidomimetics.

Kang CW, Sun Y, Del Valle JR. Kang CW, et al. Org Lett. 2012 Dec 21;14(24):6162-5. doi: 10.1021/ol302850n. Epub 2012 Dec 4. Org Lett. 2012. PMID: 23210770 Free PMC article.

4

Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.

Ranatunga S, Tang CH, Kang CW, Kriss CL, Kloppenburg BJ, Hu CC, Del Valle JR. Ranatunga S, et al. Among authors: kang cw. J Med Chem. 2014 May 22;57(10):4289-301. doi: 10.1021/jm5002452. Epub 2014 May 2. J Med Chem. 2014. PMID: 24749861 Free PMC article.

5

Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy.

Shao A, Xu Q, Spalek WT, Cain CF, Kang CW, Tang CA, Del Valle JR, Hu CA. Shao A, et al. Among authors: kang cw. Mol Cancer Ther. 2020 Dec;19(12):2432-2444. doi: 10.1158/1535-7163.MCT-20-0127. Epub 2020 Oct 13. Mol Cancer Ther. 2020. PMID: 33051362 Free PMC article.

6

IRE-1-Targeting Caged Prodrug with Endoplasmic Reticulum Stress-Inducing and XBP-1S-Inhibiting Activities for Cancer Therapy.

Shao A, Xu Q, Kang CW, Cain CF, Lee AC, Tang CA, Del Valle JR, Hu CA. Shao A, et al. Among authors: kang cw. Mol Pharm. 2022 Apr 4;19(4):1059-1067. doi: 10.1021/acs.molpharmaceut.1c00639. Epub 2022 Mar 7. Mol Pharm. 2022. PMID: 35253431 Free PMC article.

7

Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.

Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu CC. Kriss CL, et al. Among authors: kang cw. Blood. 2012 Aug 2;120(5):1027-38. doi: 10.1182/blood-2011-11-394346. Epub 2012 Jun 12. Blood. 2012. PMID: 22692508 Free PMC article.

8

Total Synthesis of L-156,373 and an oxoPiz Analogue via a Submonomer Approach.

Elbatrawi YM, Kang CW, Del Valle JR. Elbatrawi YM, et al. Among authors: kang cw. Org Lett. 2018 May 4;20(9):2707-2710. doi: 10.1021/acs.orglett.8b00912. Epub 2018 Apr 18. Org Lett. 2018. PMID: 29667833

9

Structural Tailoring of a Novel Fluorescent IRE-1 RNase Inhibitor to Precisely Control Its Activity.

Shao A, Kang CW, Tang CH, Cain CF, Xu Q, Phoumyvong CM, Del Valle JR, Hu CC. Shao A, et al. Among authors: kang cw. J Med Chem. 2019 Jun 13;62(11):5404-5413. doi: 10.1021/acs.jmedchem.9b00269. Epub 2019 May 22. J Med Chem. 2019. PMID: 31083990 Free PMC article.

10

Synthesis of Enantiopure ε-Oxapipecolic Acid.

Howard EH, Cain CF, Kang C, Del Valle JR. Howard EH, et al. J Org Chem. 2020 Feb 7;85(3):1680-1686. doi: 10.1021/acs.joc.9b02382. Epub 2019 Nov 8. J Org Chem. 2020. PMID: 31661266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page